Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115M
-
Number of holders
-
297
-
Total 13F shares, excl. options
-
68.2M
-
Shares change
-
+2.69M
-
Total reported value, excl. options
-
$2.95B
-
Value change
-
+$98.8M
-
Put/Call ratio
-
0.49
-
Number of buys
-
157
-
Number of sells
-
-150
-
Price
-
$43.28
Significant Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q4 2018
362 filings reported holding GMED - GLOBUS MEDICAL INC - Class A Stock as of Q4 2018.
GLOBUS MEDICAL INC - Class A Stock (GMED) has 297 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 68.2M shares
of 115M outstanding shares and own 59.21% of the company stock.
Largest 10 shareholders include BlackRock Inc. (9.51M shares), Vanguard Group Inc (7.03M shares), WELLINGTON MANAGEMENT GROUP LLP (5.21M shares), JANUS HENDERSON GROUP PLC (2.85M shares), AQR CAPITAL MANAGEMENT LLC (2.51M shares), STATE STREET CORP (2.47M shares), Investec Asset Management LTD (1.5M shares), Bank of New York Mellon Corp (1.48M shares), MANUFACTURERS LIFE INSURANCE COMPANY, THE (1.35M shares), and Van Berkom & Associates Inc. (1.26M shares).
This table shows the top 297 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.